Key result
Cardiometabolic multimorbidity linked to a dose-response increase in depressive symptoms among the oldest-old.
Why the study?
Depression frequently accompanies cardiometabolic multimorbidity, but whether this association persists in very old individuals remains unclear.
Does cardiometabolic multimorbidity increase depressive symptoms in individuals aged 80 years and older?
Cross-Sectional (n=1,863)
Does cardiometabolic multimorbidity increase depressive symptoms in individuals aged 80 years and older?
Cardiometabolic multimorbidity is associated with increased depressive symptoms in a dose-response manner among individuals aged 80 years and older.
Answers are grounded in this paper and cite their sources.
May warrant depression screening in multimorbid oldest-old; leaves open causality and needs longitudinal confirmation.
BACKGROUND: Depression often accompanies cardiometabolic multimorbidity (CMM), but it remains unclear whether this association persists in very old people. Hence, we examined the link between CMM and depressive symptoms in an oldest-old population. METHODS: Using cross-sectional data from a representative sample of individuals aged 80 years and older in North Rhine-Westphalia, Germany (N = 1,863), we constructed an additive disease index covering seven cardiometabolic diseases (CMDs): myocardial infarction, heart failure, hypertension, stroke, diabetes mellitus, kidney disease, and obesity. Depressive symptoms were assessed using the short form of the Depression in Old Age Scale (0 to 4 points). We employed multivariable linear regression models to study associations of CMD index (0, 1, 2, ≥ 3 CMDs) and CMD count (0 to 7 diseases) with depressive symptoms, adjusting for age, sex, socio-economic index, respiratory and pulmonary disease, cancer, and liver disease. RESULTS: Participants had a mean depressive symptom score of 0.94, and 44% reported two or more CMDs. Heart failure, hypertension, stroke, and obesity were each individually associated with more depressive symptoms. Participants with two (β = 0.30; 95%-CI: 0.12-0.48), and three or more CMDs (β = 0.40; 95%-CI: 0.18-0.62) showed higher depressive symptoms compared to those with no CMD, i.e., each additional CMD was associated with a 0.30-unit or 0.40-unit increase in depressive symptoms, respectively. We observed an additive dose-response association between CMD count and depressive symptoms (β = 0.16; 95%-CI: 0.09-0.23), slightly more pronounced for women (β = 0.19; 95%-CI: 0.10-0.29) than for men (β = 0.10, 95%-CI: 0.02-0.19). CONCLUSIONS: Individuals with CMM showed increased depressive symptomatology, indicating the need to address both physical and mental health in oldest-old individuals with high CMD burden. However, the cross-sectional study design prevents conclusions about causality and warrants further longitudinal studies.
No takes yet. Share an insight, caveat, or question.
Maschke et al. (2025) conducted a cross-sectional in Cardiometabolic multimorbidity and depressive symptoms (n=1,863). Cardiometabolic multimorbidity (CMD count) vs. No cardiometabolic disease was evaluated on Depressive symptoms (assessed using the short form of the Depression in Old Age Scale) (β 0.16, 95% CI 0.09-0.23). Cardiometabolic multimorbidity was associated with a dose-response increase in depressive symptoms among the oldest-old.
Synapse has enriched 10 related papers. Consider them for comparative context: